Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07016997 | A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors. | recruiting | Phase 1 | 70 | Chiome Bioscience Inc.INDUSTRY | 1 | Jun 12, 2025 | clinicaltrials |
| NCT06883149 | PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor | recruiting | Phase 1 | 25 | Chinese PLA General HospitalOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT07004296 |
| A Study of HDM2005 in Patients With Advanced Solid Tumor |
| recruiting |
| Phase 1 |
| 72 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.INDUSTRY |
| 1 |
| Jun 8, 2025 |
| clinicaltrials |
| NCT06987500 | A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment | recruiting | Phase 1 / Phase 2 | 132 | Evopoint Biosciences Inc.INDUSTRY | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06653777 | Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells(AcSé PEMI) | recruiting | Phase 2 | 40 | UNICANCEROTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06878612 | a Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors | recruiting | Phase 1 | 9 | Xingchen PengOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06603844 | First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor. | recruiting | Phase 1 / Phase 2 | 156 | Corbus Pharmaceuticals Inc.INDUSTRY | 2 | Jun 3, 2025 | clinicaltrials |
| NCT06943820 | AK129 Combination Therapy for Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 230 | AkesoINDUSTRY | 1 | Jun 3, 2025 | clinicaltrials |
| NCT05518253 | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors | recruiting | Phase 1 | 30 | Weijia Fang, MDOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06954077 | A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors | recruiting | Phase 1 | 45 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 31, 2025 | clinicaltrials |
| NCT04866641 | Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 40 | Taivex Therapeutics CorporationINDUSTRY | 1 | May 30, 2025 | clinicaltrials |
| NCT05541822 | To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation | recruiting | Phase 2 | 178 | Abion IncINDUSTRY | 3 | May 22, 2025 | clinicaltrials |
| NCT05144698 | RAPA-201 Therapy of Solid Tumors | recruiting | Phase 1 / Phase 2 | 37 | Rapa Therapeutics LLCINDUSTRY | 1 | May 14, 2025 | clinicaltrials |
| NCT06958679 | Evaluation of SYS6005 in Patients With Advanced Malignant Tumor | recruiting | Phase 1 | 132 | CSPC Megalith Biopharmaceutical Co.,Ltd.INDUSTRY | 1 | May 14, 2025 | clinicaltrials |
| NCT06969742 | Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers | recruiting | N/A | 120 | National Cancer Center, KoreaOTHER_GOV | 1 | May 14, 2025 | clinicaltrials |
| NCT06971523 | A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies | recruiting | Phase 1 / Phase 2 | 224 | CytosinLab Therapeutics Co., Ltd.INDUSTRY | 1 | May 14, 2025 | clinicaltrials |
| NCT06307925 | A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 122 | HC Biopharma Inc.INDUSTRY | 1 | May 13, 2025 | clinicaltrials |
| NCT06968572 | Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion | recruiting | Phase 1 | 245 | Haisco Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | May 13, 2025 | clinicaltrials |
| NCT06304571 | A Study of HC006 in Subjects With Advanced Solid Tumors | recruiting | Phase 1 | 76 | HC Biopharma Inc.INDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT05263960 | A Study of CM350 in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 248 | Keymed Biosciences Co.LtdINDUSTRY | 1 | May 4, 2025 | clinicaltrials |
| NCT06497010 | An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment | recruiting | Early Phase 1 | 40 | The Affiliated Hospital Of Guizhou Medical UniversityOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06954558 | A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor(GUARDIAN) | recruiting | Phase 1 | 15 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06669975 | A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 85 | AP Biosciences Inc.INDUSTRY | 1 | Apr 25, 2025 | clinicaltrials |
| NCT06907628 | A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 150 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Apr 25, 2025 | clinicaltrials |
| NCT06895928 | A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors | recruiting | Phase 2 | 400 | Shanghai Hengrui Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 22, 2025 | clinicaltrials |
| NCT05749432 | A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 51 | Ganzhou Hemay Pharmaceutical Co., LtdINDUSTRY | 1 | Apr 18, 2025 | clinicaltrials |
| NCT05473624 | Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 153 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06927349 | A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors. | recruiting | Phase 1 | 70 | Shandong Boan Biotechnology Co., LtdINDUSTRY | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06094556 | An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 240 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Apr 13, 2025 | clinicaltrials |
| NCT04775485 | A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors(FIREFLY-1) | recruiting | Phase 2 | 141 | Day One Biopharmaceuticals, Inc.INDUSTRY | 11 | Apr 10, 2025 | clinicaltrials |
| NCT06431243 | A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 132 | Chengdu Zenitar Biomedical Technology Co., LtdINDUSTRY | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06096974 | Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS | recruiting | Phase 1 | 60 | Shanghai YingLi Pharmaceutical Co. Ltd.INDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06621563 | Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors(HS-20117) | recruiting | Phase 1 | 780 | Hansoh BioMedical R&D CompanyINDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06710379 | A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors | recruiting | Phase 1 | 68 | Adcentrx TherapeuticsINDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT05544240 | Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors | recruiting | Phase 1 | 20 | Williams Cancer FoundationOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06911333 | AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors(AD1208) | recruiting | Phase 1 / Phase 2 | 36 | Avelos Therapeutics Inc.INDUSTRY | 1 | Apr 4, 2025 | clinicaltrials |
| NCT05269316 | Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 61 | Impact Therapeutics, Inc.INDUSTRY | 4 | Apr 1, 2025 | clinicaltrials |
| NCT05477849 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors | recruiting | Phase 1 | 30 | Shanghai Virogin Biotech Co., Ltd.INDUSTRY | 1 | Apr 1, 2025 | clinicaltrials |
| NCT05916248 | Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors | recruiting | Early Phase 1 | 34 | Ruijin HospitalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT05784688 | Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 140 | TiumBio Co., Ltd.INDUSTRY | 2 | Mar 30, 2025 | clinicaltrials |
| NCT06150365 | Personalized KSX01-TCRT in Patients With Advanced Solid Tumors | recruiting | Early Phase 1 | 12 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06716619 | A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors | recruiting | Phase 1 | 32 | Guangzhou FineImmune Biotechnology Co., LTD.INDUSTRY | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06895733 | Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1) | recruiting | Phase 1 / Phase 2 | 65 | Tianjin Medical University Second HospitalOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06897228 | PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors | recruiting | Phase 1 | 18 | Shenzhen Celconta Life Science Co., Ltd.INDUSTRY | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06894082 | Study of Radiology Manipulator Work Validation by the Radiologist(Cimer) | recruiting | — | 87 | Institut Paoli-CalmettesOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT05146440 | Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor(PRIME) | recruiting | Phase 1 / Phase 2 | 195 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT05970016 | A Phase I/II Clinical Study in Patients with Advanced Solid Tumor. | recruiting | Phase 1 / Phase 2 | 56 | Beijing Tide Pharmaceutical Co., LtdINDUSTRY | 1 | Mar 21, 2025 | clinicaltrials |
| NCT05828459 | First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors | recruiting | Phase 1 | 150 | Onward TherapeuticsINDUSTRY | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06883539 | A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. | recruiting | Phase 1 | 24 | LaunXP Biomedical Co., Ltd.INDUSTRY | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05142423 | A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 198 | AkesoINDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jun 12, 2025source: clinicaltrials